Periodical
Early Immunosuppression As Cytokine Release Syndrome Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study.
| العنوان: | Early Immunosuppression As Cytokine Release Syndrome Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study. |
|---|---|
| المؤلفون: | Colunga-Pedraza, Perla R., Barrios-Ruiz, Juan F, Treviño-Garza, Sergio, Gomez-De Leon, Andres, Guzmán-Martínez, Zulia, Colunga-Pedraza, Julia E., Cantu-Rodriguez, Olga G, Gutiérrez-Aguirre, César H, Tarín-Arzaga, Luz, Moncada-Saucedo, Nidia, Salazar-Riojas, Rosario, Vaquera-Alfaro, Héctor Alejandro, Mancias-Guerra, Consuelo, Gómez-Almaguer, David, Gonzalez-Llano, Oscar |
| المصدر: | Transplantation and Cellular Therapy; February 2024, Vol. 30 Issue: 2, Number 2 Supplement 1 pS61-S62, 2p |
| مستخلص: | Cytokine release syndrome (CRS) is a common complication following haploidentical hematopoietic stem-cell transplantation (haplo-HSCT), manifesting in over 70% of transplantations. Currently, there is no established prophylactic treatment for CRS. However, preliminary non-randomized data suggest that the early initiation of immunosuppressive graft-versus-host disease (GVHD) prophylaxis may reduce CRS incidence. |
| قاعدة البيانات: | Supplemental Index |
Full Text Finder | تدمد: | 26666375 26666367 |
|---|---|
| DOI: | 10.1016/j.jtct.2023.12.097 |